July 06, 2012

MYLAN PHARMACEUTICALS INC. v. WARNER CHILCOTT PUBLIC LIMITED COMPANY et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. May 15, 2015

    Mylan To Appeal Dismissal Of Doryx Product-Hopping Suit

    Mylan Pharmaceuticals Inc. told a Pennsylvania federal judge Thursday that it would urge the Third Circuit to overturn his ruling that tossed the generic-drug maker’s allegations that Warner Chilcott PLC tried to block generic competition for its acne medication Doryx by tweaking its formula.

10 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS